152 related articles for article (PubMed ID: 18453785)
1. [Development of acute coronary syndrome in three patients with essential thrombocythemia or polycythemia vera].
Tekin M; Gökaslan S; Diker E; Aydoğdu S
Turk Kardiyol Dern Ars; 2008 Jan; 36(1):35-8. PubMed ID: 18453785
[TBL] [Abstract][Full Text] [Related]
2. Acute coronary disease in essential thrombocythemia and polycythemia vera.
Rossi C; Randi ML; Zerbinati P; Rinaldi V; Girolami A
J Intern Med; 1998 Jul; 244(1):49-53. PubMed ID: 9698024
[TBL] [Abstract][Full Text] [Related]
3. Anticoagulant-resistant thrombophilia in a patient with polycythemia vera: a case report.
Das S; Karachiwala H; Cherian SV; Garcha AS; Jasti S; Gajra A
Blood Coagul Fibrinolysis; 2011 Dec; 22(8):746-8. PubMed ID: 21885951
[TBL] [Abstract][Full Text] [Related]
4. Acute myocardial infarction revealing a polycythemia vera.
Gouri A; Yakhlef A; Dekaken A; Bentorki AA
Ann Biol Clin (Paris); 2012; 70(4):489-91. PubMed ID: 22796622
[TBL] [Abstract][Full Text] [Related]
5. Platelet-mediated erythromelalgic, cerebral, ocular and coronary microvascular ischemic and thrombotic manifestations in patients with essential thrombocythemia and polycythemia vera: a distinct aspirin-responsive and coumadin-resistant arterial thrombophilia.
Michiels JJ; Berneman Z; Schroyens W; Koudstaal PJ; Lindemans J; Neumann HA; van Vliet HH
Platelets; 2006 Dec; 17(8):528-44. PubMed ID: 17127481
[TBL] [Abstract][Full Text] [Related]
6. The management of acute myocardial infarction in a patient with polycythemia rubra vera during the thrombolytic era--does it make a difference?
Chan AW; Drobac M; Sternberg L
Can J Cardiol; 1997 Jan; 13(1):59-63. PubMed ID: 9039066
[TBL] [Abstract][Full Text] [Related]
7. Aspirin-responsive painful red, blue, black toe, or finger syndrome in polycythemia vera associated with thrombocythemia.
Michiels JJ; Berneman Z; Schroyens W; van Urk H
Ann Hematol; 2003 Mar; 82(3):153-9. PubMed ID: 12634947
[TBL] [Abstract][Full Text] [Related]
8. Recurrent thrombosis in patients with polycythemia vera and essential thrombocythemia: incidence, risk factors, and effect of treatments.
De Stefano V; Za T; Rossi E; Vannucchi AM; Ruggeri M; Elli E; Micò C; Tieghi A; Cacciola RR; Santoro C; Gerli G; Vianelli N; Guglielmelli P; Pieri L; Scognamiglio F; Rodeghiero F; Pogliani EM; Finazzi G; Gugliotta L; Marchioli R; Leone G; Barbui T;
Haematologica; 2008 Mar; 93(3):372-80. PubMed ID: 18268279
[TBL] [Abstract][Full Text] [Related]
9. Myocardial infarction and polycythemia vera: how should we treat it?
Venegoni P; Schroth G
Cathet Cardiovasc Diagn; 1994 Jul; 32(3):259-61. PubMed ID: 7954775
[TBL] [Abstract][Full Text] [Related]
10. Diagnosis and treatment of thrombocythemia in myeloproliferative disorders.
Gilbert HS
Oncology (Williston Park); 2001 Aug; 15(8):989-96, 998; discussion 999-1000,1006,1008. PubMed ID: 11548978
[TBL] [Abstract][Full Text] [Related]
11. [Anti thrombotic therapy after coronary thrombolysis].
Tani S; Kanmatsuse K
Nihon Rinsho; 2003 Apr; 61 Suppl 4():484-8. PubMed ID: 12735020
[No Abstract] [Full Text] [Related]
12. Polycythemia vera and essential thrombocythemia: 2013 update on diagnosis, risk-stratification, and management.
Tefferi A
Am J Hematol; 2013 Jun; 88(6):507-16. PubMed ID: 23695894
[TBL] [Abstract][Full Text] [Related]
13. Polycythemia vera and essential thrombocythemia: 2012 update on diagnosis, risk stratification, and management.
Tefferi A
Am J Hematol; 2012 Mar; 87(3):285-93. PubMed ID: 22331582
[TBL] [Abstract][Full Text] [Related]
14. Annual Clinical Updates in Hematological Malignancies: a continuing medical education series: polycythemia vera and essential thrombocythemia: 2011 update on diagnosis, risk-stratification, and management.
Tefferi A
Am J Hematol; 2011 Mar; 86(3):292-301. PubMed ID: 21351120
[TBL] [Abstract][Full Text] [Related]
15. Honeycomb-like structure (HLS) in the left anterior-descending coronary artery-recanalized thrombus demonstrated by intravascular ultrasound (IVUS) in a patient with polycythemia vera and thrombocythemia.
Gao X; Liu B; Li X; Ma S; Su G; Li Z
Herz; 2023 Dec; 48(6):470-473. PubMed ID: 37566118
[TBL] [Abstract][Full Text] [Related]
16. The risk of thrombosis in essential thrombocythemia and polycythemia vera.
Pearson TC
Semin Oncol; 2002 Jun; 29(3 Suppl 10):16-21. PubMed ID: 12096353
[TBL] [Abstract][Full Text] [Related]
17. Hematologic aspects of liver transplantation for Budd-Chiari syndrome with special reference to myeloproliferative disorders.
Melear JM; Goldstein RM; Levy MF; Molmenti EP; Cooper B; Netto GJ; Klintmalm GB; Stone MJ
Transplantation; 2002 Oct; 74(8):1090-5. PubMed ID: 12438952
[TBL] [Abstract][Full Text] [Related]
18. [Acute myocardial infarction due to polycythemia vera].
Huart J; Visée C; Colassin A; Maréchal P; Hafraoui K; Davin L
Rev Med Liege; 2018 Jul; 73(7-8):397-401. PubMed ID: 30113781
[TBL] [Abstract][Full Text] [Related]
19. Erythromelalgia and vascular complications in polycythemia vera.
Michiels JJ
Semin Thromb Hemost; 1997; 23(5):441-54. PubMed ID: 9387203
[TBL] [Abstract][Full Text] [Related]
20. Expertise-based management in essential thrombocythemia and polycythemia vera.
Finazzi G; Barbui T
Cancer J; 2007; 13(6):372-6. PubMed ID: 18032974
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
